Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Beta3-adrenoceptor agonists with utility in type 2 diabetes

March 7, 2002

Synaptic identifies new compounds for eating disorders

March 6, 2002

Vitronectin receptor antagonists for use in osteoporosis, etc.

March 6, 2002

Beta3-adrenoceptor agonists claimed for the treatment of obesity and type 2 diabetes

March 5, 2002

New patent covers compounds for conditions associated with undesirable bone resorption

March 5, 2002

FDA accepts Zetia NDA filing for hypercholesterolemia

March 5, 2002

Comparison of safety and efficacy of three drugs for the treatment of obesity

March 5, 2002

Compounds for use in diseases associated with hypercholesterolemia described by BASF

March 4, 2002

Scientists at Genentech describe c-mpl agonist antibodies

March 4, 2002

Once- or twice-yearly i.v. zoledronic acid effective in postmenopausal osteoporosis

March 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...